High-Throughput Screening: Technologies and Global Markets

Report Code: PHM205B

Publish Date: Feb 2025

Publisher: BCC Publishing

Category: Pharmaceuticals

Download Report Overview

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for high-throughput screening (HTS) is expected to grow from $23.8 billion in 2024 to $39.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.5% from 2024 through 2029.

Report Includes

  • 154 data tables and 46 additional tables
  • An analysis of the global market for high-throughput screening (HTS) technologies
  • Analyses of the global market trends, with market revenue data (sales figures) from 2021 and 2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
  • Estimates of the market size and revenue growth prospects, along with a market share analysis by component, application, technology type, detection method, end user, and region
  • Facts and figures pertaining to key market dynamics, technology advances, regulations, and the impact of macroeconomic factors
  • Insights derived from the Porter’s Five Forces model, as well as global supply chain analyses
  • Analysis of patent activity, featuring key granted and published patents
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
  • Company profiles of leading players, including Danaher Corp., Thermo Fisher Scientific Inc., Charles River Laboratories, Revvity and Bio-Rad Laboratories Inc.

Report Scope

The current report will provide detailed exposure to the high-throughput screening (HTS) market. This report analyzes the market trends of HTS with data from 2023, estimates from 2024, projections of compound annual growth rates (CAGRs) through 2029 (forecast period is from 2024 through 2029) and regional HTS markets. This report will highlight the current and future market potential of HTS and present a detailed analysis of the competitive environment. It will also cover regulatory scenarios, drivers, restraints and opportunities. Lastly, it presents the market share for key market players.

The market scope in this report is segmented into detection method, component, technology and end user. The report covers spectroscopy, mass spectrometry, chromatography, calorimetry, X-ray diffraction and microscopy based on detection methods. These detection methods are further classified into subcategories for this report. The market is segmented based on components into instruments/
platforms, consumables (e.g., reagents, kits), services and software, and analytics (e.g., bioinformatics). The market is segmented based on technology: cell-based assays, ultra-high-throughput screening, label-free technology and lab-on-a-chip. End users are segmented into pharmaceutical and biotechnology companies, contract research organizations (CROs), research and government institutes, and lab and pathological practices.

The market has been segmented into significant geographical regions: North America, Europe, Asia-Pacific and other world regions. The regional segment will cover a detailed analysis of major countries, including the U.S., Canada, Germany, the U.K., Italy, Spain, France, Japan, China, South Korea, Australia and India. Data from 2023 will be provided as the base year for market estimates, with forecasts for 2024 through 2029.

The report’s goals include:

  • Analyzing technologies, components, end users and applications.
  • Analyzing global market size and segmentation.
  • Understanding market constraints and drivers.
  • Providing detailed market forecasts for 2029.
  • Assessing market shares, competitiveness and industry structure.
  • Identifying potential long-term impacts on the high-throughput screening market.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $21.6 Billion
Market size forecast $39.2 Billion
Growth rate CAGR of 10.5% from 2024 to 2029
Units considered $ Millions
Segments covered Detection Method, Component, Technology Type, Application, End User, and Region
Regions covered North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
Countries covered The U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Japan, China, India, South Korea and Australia
Key Market Drivers
  • Increased adoption of contract research organizations (CROs).
  • Technological innovation leads to advanced tools and methods.
  • Rising government funding and business research and development (R&D) expenditures.
  • Rising prevalence of chronic and immunological diseases.
Companies studied
BIO-TECHNEAGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.CORNING INC.
BRUKERCHARLES RIVER LABORATORIES
CREATIVE BIOLABSCURIOX BIOSYSTEMS
DANAHER CORP.EVOTEC SE
PROMEGA CORP.REVVITY
THERMO FISHER SCIENTIFIC INC.VALA SCIENCES INC.
ZEISS
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global market for high-throughput screening was valued at $21.6 billion in 2023 and is projected to reach $39.2 billion by the end of 2029.
High-throughput screening will undoubtedly accelerate over the coming decades owing to the increased adoption of contract research organizations (CROs), technological innovation leads to advanced tools and methods, rising government funding and business R&D expenditures, and rising prevalence of chronic and immunological diseases.
The market scope in this report is segmented into detection method, component, technology and end-user. Based on detection methods, the report covers spectroscopy, mass spectrometry, chromatography, calorimetry, x-ray diffraction, and microscopy. These detection methods are further classified into subcategories for the purpose of this report. The market is segmented based on components into instruments/platform, consumables (reagents and kits), services and software and analytics (bioinformatics). On the basis of technology, the market is segmented into cell-based assays, ultra-high-throughput screening, label-free technology and lab-on-a-chip. By end user the market is segmented into pharmaceutical and biotechnology companies, contract research organizations, research and government institutes and lab and pathologies.
The Spectroscopy segment will dominate the high-throughput screening market.
The North American market for high-throughput screening was valued at $12.6 billion in 2023 and is estimated to reach $23.1 billion in 2029, at a CAGR of 10.7% during the forecast period.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Mariana Kuznietsova, a Life Science Consultant at BCC Research, has 8 years of experience in both academic and industry research developing biochemical and biotechnological applications and laboratory services. She also has a strong background in laboratory equipment trading services covering technical support, complex lab solutions to meet demands of laboratories from a range of areas, such as Academia, Agriculture, Pharma, and Food and Beverage. Mariana holds a Ph.D. in Biochemistry from the Taras Shevchenko National University of Kyiv, Ukraine.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: High-Throughput Screening: Technologies and Global Markets265Free
Chapter- 1: Executive Summary4Free
Chapter- 2: Market Overview3Free
Chapter- 3: Market Dynamics16Free
Chapter- 4: Emerging Technologies7Free
Chapter- 5: Market Segmentation Analysis174Free
Chapter- 6: Competitive Intelligence3Free
Chapter- 7: Sustainability in the High-Throughput Screening Market: An ESG Perspective7Free
Chapter- 8: Appendix51Free
Published - Feb-2019| Analyst - Anuj Pathak| Code - PHM205A

Report Highlights

The global high-throughput screening (HTS) market should reach $21.1 billion by 2023 from $14.4 billion in 2018 at a compound annual growth rate (CAGR) of 7.9% for the period 2018-2023.

Related Reports

2023 Pharmaceuticals Research Review

Published - Dec 2024 | Publisher - Various Analysts | Code - PHM099H

This Pharmaceutical Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making since the inception of BCC Research in 1971.

Active Pharmaceutical Ingredients: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM200C

The global market for active pharmaceutical ingredients (APIs) is estimated to increase from $247.8 billion in 2023 to reach $347.9 billion by 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.

Bioinformatics: Technologies and Global Markets

Published - Dec 2023 | Publisher - Partha Sarathi Das | Code - BIO051G

The global market for bioinformatics is expected to grow from $18.7 billion in 2023 to $35.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 13.6% during the forecast period of 2023-2028.

Global Markets for Artificial Intelligence in Drug Discovery

Published - Sep 2023 | Publisher - BCC Publishing | Code - HLC290A

The global market for artificial intelligence (AI) in drug discovery is estimated to increase from $1.6 billion in 2023 to $5.7 billion by 2028, at a compound annual growth rate (CAGR) of 29.6% from 2023 through 2028.

Recent Reports

High-Throughput Screening: Technologies and Global Markets

Published - Feb 2025 | Publisher - BCC Publishing | Code - PHM205B

The global market for high-throughput screening (HTS) is expected to grow from $23.8 billion in 2024 to $39.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.5% from 2024 through 2029.

Neurology Market: A BCC Research Overview

Published - Feb 2025 | Publisher - BCC Publishing | Code - PHM215B

The global market for neurology is estimated to increase from $67.3 billion in 2024 to reach $94.8 billion by 2029, at a compound annual growth rate (CAGR) of 7.1% from 2024 through 2029.

2023 Pharmaceuticals Research Review

Published - Dec 2024 | Publisher - Various Analysts | Code - PHM099H

This Pharmaceutical Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making since the inception of BCC Research in 1971.

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM062E

The global market for Alzheimer’s disease therapeutics and diagnostics was valued at $9 billion in 2023. This market is expected to grow from $9.7 billion in 2024 to $19.6 billion by 2029, at a compound annual growth rate (CAGR) of 15.1% from 2024 to 2029.

Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM204C

The global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

Top Trending Reports

Biomarkers: Technologies and Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - BIO061G

The global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% from 2024 through 2029.

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM062E

The global market for Alzheimer’s disease therapeutics and diagnostics was valued at $9 billion in 2023. This market is expected to grow from $9.7 billion in 2024 to $19.6 billion by 2029, at a compound annual growth rate (CAGR) of 15.1% from 2024 to 2029.

In Vitro Diagnostics: Technologies and Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - HLC186D

The global market for In Vitro Diagnostics (IVD) is expected to grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

OTC Drugs, Medical Devices and Diagnostics: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - HLC251B

The global market for OTC drugs, medical devices, and diagnostics is estimated to increase from $251.7 billion in 2024 to reach $359.7 billion by 2029, at a compound annual growth rate (CAGR) of 7.4% from 2024 through 2029.

Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - BIO150E

The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
High-Throughput Screening: Technologies and Global Markets
Sample Report